Abbott secures expanded FDA approval for Proclaim DRG neurostimulation system
Proclaim is an FDA-approved DRG technology that provides targeted relief for people with complex regional pain syndrome (CRPS),…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
19 Jan 24
Proclaim is an FDA-approved DRG technology that provides targeted relief for people with complex regional pain syndrome (CRPS),…
19 Jan 24
Enigma Biomedical and AbbVie will develop and market AbbVie’s F18 PET imaging biomarkers targeting four-repeat (4R) tau protein…
19 Jan 24
The research use only test is a tumour-naïve plasma-based test designed to assess circulating tumour DNA (ctDNA) in…
19 Jan 24
BoneMRI with the 7D FLASH Navigation System is said to offer fully radiation-free preoperative imaging and spinal navigation…
19 Jan 24
Calcivis has developed a completely novel imaging technology that enables clinicians to visualize early signs of active decay
19 Jan 24
HemON NL is evaluating the use of ARC-IM Therapy to address hemodynamic instability after spinal cord injury
18 Jan 24
The device leverages spectroscopy technology and an AI-powered algorithm to provide primary care physicians (PCPs) with immediate, accurate,…
18 Jan 24
Clarius PAL HD3 is a dual-array ultrasound scanner that combines phased and linear arrays on a single head…
18 Jan 24
The new test, created and patented by Guy Adami and Joel Schwartz of the UIC College of Dentistry,…
18 Jan 24
Stryker is a global leader in medical technologies and, together with its customers, is driven to make healthcare…